J&J Covid vaccine recipients are higher off getting Pfizer or Moderna booster, NIH research suggests
Pfizer-BioNTech Covid-19 vaccines at a senior dwelling facility in Worcester, Pennsylvania, U.S., on Wednesday, Aug. 25, 2021.
Hannah Beier | Bloomberg | Getty Pictures
Johnson & Johnson Covid-19 vaccine recipients are higher off getting a booster shot from Pfizer or Moderna, a extremely anticipated U.S. research recommended Wednesday.
The research on “mixing and matching” Covid vaccines included greater than 450 adults who’ve obtained one of many three regimens presently obtainable in the USA: J&J’s, Moderna’s or Pfizer’s. The research hasn’t but been peer-reviewed.
This can be a creating story. Please test again for updates.